Skip to main content

Table 1 Characteristics of the 800 participants by AHD treatment group

From: Cluster analysis of angiotensin biomarkers to identify antihypertensive drug treatment in population studies

AHD group

N

Sex

M/F

Age, years

mean(SD)

SBP, mmHg

mean(SD)

DBP, mmHg

mean(SD)

BMI, kg/m2

mean(SD)

Normotensive

101

46/55

64.9(7.2)

122.3(9.4)

78.7(6.4)

25.9(3.4)

Hypertensive

100

46/54

62.1(7.8)

146.7(12.2)

93.0(7.2)

27.2(4.4)

Non-AHD

100

46/54

68.8(10.1)

131.2(18.4)

81.0(8.3)

26.3(4.3)

Beta blockers

100

46/54

66.2(9.0)

134.6(16.8)

83.7(8.9)

28.2(4.8)

ACEi

99

45/54

68.7(10.0)

142.5(18.0)

85.5(9.4)

28.7(4.2)

ACEi + diuretics

100

47/53

68.6(10.0)

138.1(18.7)

84.0(8.2)

29.8(4.3)

ARB

98

45/53

65.2(9.5)

134.9(15.0)

84.7(8.4)

28.6(4.8)

ARB + diuretics

102

47/55

68.7(9.9)

139.9(17.9)

86.1(9.3)

30.5(5.6)

Overall

800

368/432

67(9.5)

136.3(17.5)

84.6(9.2)

28.1(4.7)